NASDAQ: TTOO       T2 Biosystems CS
Last Price Today's Change   Day's Range   Trading Volume
0.254   -0.036 (12.41%)  0.24 - 0.28  73,956,700


Avg Volume (4 weeks):93,164,708
4 Weeks Range:0.23 - 0.469
4 Weeks Price Volatility (%):
52 Weeks Range:0.05 - 2.35
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

T2 Biosystems Inc provides rapid in vitro diagnostic tests. Its panels are focused on bacterial sepsis infections, hemostasis, and Lyme disease. Its core technology is the T2 magnetic resonance platform, which can detect a variety of targets, including DNA, proteins, and hemostasis measurements. Using this technology, the firm has also developed the T2Dx, a benchtop instrument that can be used to detect sepsis and Lyme disease, among other applications. The T2Dx is fully automated from patient sample to result and includes panels for Candida and other bacteria that can lead to sepsis.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

3201  6540  1227  356 

Top 10 Active Counters
 AVTX 0.119+0.016 
 EBET 0.068-0.008 
 LIFW 0.237-0.001 
 APE 1.42-0.31 
 SQQQ 20.47-0.01 
 TSLA 244.88-10.82 
 SPY 430.42-0.97 
 TQQQ 35.625+0.025 
 MLGO 4.78+0.74 
 TTOO 0.254-0.036